Metabolic Bone Disorder Active Not Recruiting Phase 4 Trials for Dapagliflozin (DB06292)

Also known as: Metabolic Bone Disease / Bone Disease, Metabolic / Bone Diseases, Metabolic / Metabolic Bone Diseases / Metabolic bone disorders / Metabolic bone disease (disorder) / Bone metabolism disorder / Bone metabolism disorders

IndicationStatusPhase
DBCOND0064775 (Metabolic Bone Disorder)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05735197Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease PatientsPrevention